Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of May 13, 2025 • 6:31 PM ET

Date/Time Source News Release
09/19/2022 04:30 PM EDT GlobeNewswire Celsion Corporation Announces Company Name Change to Imunon, Inc.
09/15/2022 08:30 AM EDT GlobeNewswire Celsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer
09/12/2022 06:30 PM EDT GlobeNewswire Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13
09/07/2022 09:15 AM EDT GlobeNewswire Celsion Corporation to Present at the H.C. Wainwright 24th Annual Global Investment Conference
09/01/2022 08:30 AM EDT GlobeNewswire Celsion Corporation Highlights Progress in its DNA-based Vaccine Program
08/15/2022 08:00 AM EDT GlobeNewswire Celsion Corporation Reports Second Quarter 2022 Financial Results and Provides Business Update
08/08/2022 08:30 AM EDT GlobeNewswire Celsion Corporation to Hold Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 15, 2022
07/19/2022 08:35 AM EDT GlobeNewswire Celsion Corporation Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
07/19/2022 08:30 AM EDT GlobeNewswire Celsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer
06/24/2022 08:35 AM EDT GlobeNewswire Life Sciences Investor Forum Presentations Now Available for On-Demand Viewing
Page

Additional News

As of May 13, 2025 • 6:31 PM ET

Date/Time Source News Release
09/19/2022 04:36 PM EDT SeekingAlpha Celsion changes name to Imunon (IMNN)
09/01/2022 09:27 AM EDT SeekingAlpha Celsion says additional data shows placcine vaccine works against COVID-19 in animal model
08/15/2022 03:31 PM EDT SeekingAlpha Celsion Corporation's (CLSN) CEO Corinne Le Goff on Q2 2022 Results - Earnings Call Transcript
08/15/2022 08:04 AM EDT SeekingAlpha Celsion GAAP EPS of -$0.87, revenue of $0.13M
08/12/2022 01:02 PM EDT SeekingAlpha Celsion Q2 2022 Earnings Preview
08/12/2022 10:53 AM EDT SeekingAlpha Notable earnings before Monday's open
07/19/2022 08:53 AM EDT SeekingAlpha Celsion adds Moderna chief commercial officer as CEO
05/18/2022 08:45 AM EDT Financial News Media Advanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression
05/16/2022 03:26 PM EDT SeekingAlpha Celsion Corporation (CLSN) CEO Michael Tardugno on Q1 2022 Results - Earnings Call Transcript
05/16/2022 08:04 AM EDT SeekingAlpha Celsion GAAP EPS of -$1.82 misses by $0.82, revenue of $0.13M beats by $0.02M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.